Skip to main content

SARS-CoV-2 Mutations: An Insight

  • Chapter
  • First Online:
Human Viruses: Diseases, Treatments and Vaccines
  • 793 Accesses

Abstract

A new terror to mankind, the novel coronavirus, known as SARS-CoV-2, previously known 2019-nCoV, is a recent member in RNA virus group and has shaken almost every country around the world. Since December 2019, world has witnessed global lockdown in different phases, and with every phase the severity of infection is increasing. Already many countries around the world are reeling under the second wave of novel coronavirus infection which is much more severe than the first wave. Although the average death rate across the world is ~2.2%, this rate varies from country to country and may be attributed to geo-distribution of different strains and rich genetic variations as the result of mutations. This chapter focuses on the hotspots of mutations across the genomes sequenced so far and the evolutionary forces leading to stabilizing these mutations. Although SARS-CoV-2 is mutating slow, nevertheless few mutations can be associated with increased infectivity.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 139.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 199.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

Abbreviations

(+) ssRNA:

Positive single stranded Ribosomal nucleic acid

ACE2:

Angiotensin-converting enzyme2

BatCoV:

Bat Coronavirus

GISAID:

Global Initiative on Sharing all Influenza Data

MERS-CoV:

Middle East respiratory syndrome coronavirus

NS:

Non-structural

NSP:

Nonstructural protein

ORF:

Open Reading Frame

RdRp:

RNA dependent RNA polymerase

SARS-CoV:

Severe acute respiratory syndrome coronavirus

SARS-CoV-2:

Severe Acute Respiratory Syndrome coronavirus 2

SNP:

Single nucleotide polymorphism

UTR:

Untranslated Region

WHCV:

Wuhan-Human 1 coronavirus

WHO:

World Health Organization

References

  • Abduljalil JM, Abduljalil BM. Epidemiology, genome, and clinical features of the pandemic SARS-CoV-2: a recent view. New Microbes New Infect. 2020;35:100672. https://doi.org/10.1016/j.nmni.2020.100672, PMID 32322400.

  • Andrews SM, Rowland-Jones S. Recent advances in understanding HIVevolution. F1000Res. 2017;6:597. https://doi.org/10.12688/f1000research.10876.1, PMID 28529718.

  • Astuti I, Ysrafil. Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): An overview of viral structure and host response. Diabetes Metab Syndr 14. 2020;2:407–12. https://doi.org/10.1016/j.dsx.2020.04.020.

  • Chen J, Wang R, Wang M, Wei GW. Mutations strengthened SARS-CoV-2 infectivity. J Mol Biol. 2020;432(19):5212–26. https://doi.org/10.1016/j.jmb.2020.07.009, PMID 32710986.

  • Chen Z-W, Li Z, Li H, Ren H, Hu P. Global genetic diversity patterns and transmissions of SARS-CoV-2. medRxiv. 2020 2020.2005.2005.20091413.

    Google Scholar 

  • Combe M, Sanjuán R. Variation in RNA virus mutation rates across host cells. PLOS Pathog. 2014;10(1):e1003855. 10.1371/journal.ppat.1003855, PMID 24465205.

    Google Scholar 

  • Costa RL, Voloch CM, Schrago CG. Comparative evolutionary epidemiology of dengue virus serotypes. Infect Genet Evol. 2012;12(2):309–14. https://doi.org/10.1016/j.meegid.2011.12.011.

    Article  PubMed  Google Scholar 

  • Cotten M, Watson SJ, Zumla AI, Makhdoom HQ, Palser AL, Ong SH, Al Rabeeah AA, Alhakeem RF, Assiri A, Al-Tawfiq JA, Albarrak A, Barry M, Shibl A, Alrabiah FA, Hajjar S, Balkhy HH, Flemban H, Rambaut A, Kellam P, Memish ZA. Spread, circulation, and evolution of the Middle East respiratory syndrome coronavirus. mBio. 2014;5(1):e01062–13. https://doi.org/10.1128/mbio.01062-13, PMID 24549846.

  • Duffy S. Why are RNA virus mutation rates so damn high? PLOS Biol. 2018;16(8):e3000003. https://doi.org/10.1371/journal.pbio.3000003, PMID 30102691.

  • Gupta V, Haider S, Verma M, Ponnusamy K, Malik MZ, Singhvi N, Verma H, Kumar R, Sood U, Hira P, et al. Multi-omics and integrated network approach to unveil evolutionary patterns, mutational hotspots, functional cross talk and regulatory interactions in SARS-CoV-2. bioRxiv. 2020. https://doi.org/10.1101/2020.06.20.162560.

  • Hosseini Rad Sm A, McLellan AD. Implications of SARS-CoV-2 mutations for genomic RNA structure and host microRNA targeting. Int J Mol Sci. 2020;21(13):4807. https://doi.org/10.3390/ijms21134807, PMID 32645951.

  • Hughes GJ, Orciari LA, Rupprecht CE. Evolutionary timescale of rabies virus adaptation to North American bats inferred from the substitution rate of the nucleoprotein gene. J Gen Virol. 2005;86(5):1467–74. https://doi.org/10.1099/vir.0.80710-0, PMID 15831959.

  • Khrustalev VV, Giri R, Khrustaleva TA, Kapuganti SK, Stojarov AN, Poboinev VV. Translation-associated mutational U-pressure in the first ORF of SARS-CoV-2 and other coronaviruses. bioRxiv. 2020. https://doi.org/10.1101/2020.05.05.078238.

  • Korber B, Fischer WM, Gnanakaran S, Yoon H, Theiler J, Abfalterer W, Hengartner N, Giorgi EE, Bhattacharya T, Foley B, Hastie KM, Parker MD, Partridge DG, Evans CM, Freeman TM, de Silva TI, Sheffield COVID-19 Genomics Group, McDanal C, Perez LG, Tang H, Moon-Walker A, Whelan SP, LaBranche CC, Saphire EO, Montefiori DC. Tracking changes in SARS-CoV-2 spike: evidence that D614G increases infectivity of the COVID-19 virus. Cell. 2020;182(4):812–827.e19. https://doi.org/10.1016/j.cell.2020.06.043, PMID 32697968.

  • Kumar R, Verma H, Singhvi N, Sood U, Gupta V, Singh M, Kumari R, Hira P, Nagar S, Talwar C, Nayyar N, Anand S, Rawat CD, Verma M, Negi RK, Singh Y, Lal R. Comparative genomic analysis of rapidly evolving SARS-CoV-2 reveals mosaic pattern of phylogeographical distribution. mSystems. 2020;5(4):e00505–20. https://doi.org/10.1128/msystems.00505-20, PMID 32723797.

  • Laamarti M, Alouane T, Kartti S, Chemao-Elfihri MW, Hakmi M, Essabbar A, Laamart M, Hlali H, Allam L, Hafidi NEL, Jaoudi REL, Allali I, Marchoudi N, Fekkak J, Benrahma H, Nejjari C, Amzazi S, Belyamani L, Ibrahimi A. Large scale genomic analysis of 3067 SARS-CoV-2 genomes reveals a clonal geo-distribution and a rich genetic variations of hotspots mutations. bioRxiv. 2020:2020.2005.2003.074567.

    Google Scholar 

  • Li Q, Guan X, Wu P, Wang X, Zhou L, Tong Y, Ren R, Leung KSM, Lau EHY, Wong JY, Xing X, Xiang N, Wu Y, Li C, Chen Q, Li D, Liu T, Zhao J, Liu M, Tu W, Chen C, Jin L, Yang R, Wang Q, Zhou S, Wang R, Liu H, Luo Y, Liu Y, Shao G, Li H, Tao Z, Yang Y, Deng Z, Liu B, Ma Z, Zhang Y, Shi G, Lam TTY, Wu JT, Gao GF, Cowling BJ, Yang B, Leung GM, Feng Z. Early transmission dynamics in Wuhan, China, of novel coronavirus- infected pneumonia. N Engl J Med. 2020;382(13):1199–207. https://doi.org/10.1056/NEJMoa2001316, PMID 31995857.

  • Llanes A, Restrepo CM, Caballero Z, Rajeev S, Kennedy MA, Lleonart R. Betacoronavirus Genomes: how Genomic Information has been Used to Deal with Past Outbreaks and the COVID-19 Pandemic. Int J Mol Sci. 2020;21(12):4546. https://doi.org/10.3390/ijms21124546, PMID 32604724.

  • Majumdar P, Niyogi S. ORF3a mutation associated with higher mortality rate in SARS-CoV-2 infection. Epidemiol Infect. 2020;148:e262. Published 2020 Oct 26. https://doi.org/10.1017/s0950268820002599, PMID 33100263.

  • Mercatelli D, Giorgi FM. Geographic and genomic distribution of SARS-CoV-2 mutations. Front Microbiol. 2020;11:1800. doi:10.3389/fmicb.2020.01800, PMID 32793182.

    Google Scholar 

  • Ogata N, Alter HJ, Miller RH, Purcell RH. Nucleotide sequence and mutation rate of the H strain of hepatitis C virus. Proc Natl Acad Sci U S A. 1991;88(8):3392–6. https://doi.org/10.1073/pnas.88.8.3392, PMID 1849654.

  • Pachetti M, Marini B, Benedetti F, Giudici F, Mauro E, Storici P, Masciovecchio C, Angeletti S, Ciccozzi M, Gallo RC, Zella D, Ippodrino R. Emerging SARS-CoV-2 mutation hot spots include a novel RNA-dependent-RNA polymerase variant. J Transl Med. 2020;18(1):179. https://doi.org/10.1186/s12967-020-02344-6, PMID 32321524.

  • Peck KM, Lauring AS. Complexities of viral mutation rates. J Virol. 2018;92(14):e01031–17. https://doi.org/10.1128/JVI.01031-17, PMID 29720522.

  • Plante JA, Liu Y, Liu J, Xia H, Johnson BA, Lokugamage KG, Zhang X, Muruato AE, Zou J, Fontes-Garfias CR, Mirchandani D, Scharton D, Bilello JP, Ku Z, An Z, Kalveram B, Freiberg AN, Menachery VD, Xie X, Plante KS, Weaver SC, Shi PY. Spike mutation D614G alters SARS-CoV-2 fitness. Nature. 2020. https://doi.org/10.1038/s41586-020-2895-3, PMID 33106671.

  • Pyrc K, Berkhout B, van der Hoek L. The novel human coronaviruses NL63 and HKU1. J Virol. 2007;81(7):3051–7. https://doi.org/10.1128/JVI.01466-06, PMID 17079323.

  • Rahimi A, Mirzazadeh A, Tavakolpour S. Genetics and genomics of SARS-CoV-2: a review of the literature with the special focus on genetic diversity and SARS-CoV-2 genome detection. Genomics. 2020;S0888–7543(20):30876-4. https://doi.org/10.1016/j.ygeno.2020.09.059, PMID 33007398.

  • Rehman SU, Shafique L, Ihsan A, Liu Q. Evolutionary trajectory for the emergence of novel coronavirus SARS-CoV-2. Pathogens. 2020;9(3):240. https://doi.org/10.3390/pathogens9030240, PMID 32210130.

  • Saiz JC, Sobrino F, Sevilla N, Martín V, Perales C, Domingo E. Molecular and evolutionary mechanisms of viral emergence. In: Singh SK, editor Viral infections and global change; 2013.

    Google Scholar 

  • Sanjuán R, Nebot MR, Chirico N, Mansky LM, Belshaw R. Viral mutation rates. J Virol. 2010;84(19):9733–48. https://doi.org/10.1128/JVI.00694-10, PMID 20660197.

  • Shang J, Ye G, Shi K, Wan Y, Luo C, Aihara H, Geng Q, Auerbach A, Li F. Structural basis of receptor recognition by SARS-CoV-2. Nature. 2020;581(7807):221–4. https://doi.org/10.1038/s41586-020-2179-y, PMID 32225175.

  • Tang Q, Song Y, Shi M, Cheng Y, Zhang W, Xia XQ. Inferring the hosts of coronavirus using dual statistical models based on nucleotide composition. Sci Rep. 2015;5:17155. https://doi.org/10.1038/srep17155, PMID 26607834.

  • van Dorp L, Richard D, Tan CCS, Shaw LP, Acman M, Balloux F. No evidence for increased transmissibility from recurrent mutations in SARS-CoV-2. Nat Commun. 2020;11(1):5986. https://doi.org/10.1038/s41467-020-19818-2, PMID 33239633.

  • Volz E, Hill V, McCrone JT, Price A, Jorgensen D, O’Toole Á, Southgate J, Johnson R, Jackson B, Nascimento FF, Rey SM, Nicholls SM, Colquhoun RM, da Silva Filipe A, Shepherd J, Pascall DJ, Shah R, Jesudason N, Li K, Jarrett R, Pacchiarini N, Bull M, Geidelberg L, Siveroni I; COG-UK Consortium, Goodfellow I, Loman NJ, Pybus OG, Robertson DL, Thomson EC, Rambaut A, Connor TR, Connor TR. Evaluating the effects of SARS-CoV-2 spike mutation D614G on transmissibility and pathogenicity. Cell. 2020 Nov 19;S0092-8674(20):31537–3. https://doi.org/10.1016/j.cell.2020.11.020, PMID 33275900, PMCID PMC7674007.

  • Weisblum Y, Schmidt F, Zhang F, DaSilva J, Poston D, Lorenzi JC, Muecksch F, Rutkowska M, Hoffmann HH, Michailidis E, Gaebler C, Agudelo M, Cho A, Wang Z, Gazumyan A, Cipolla M, Luchsinger L, Hillyer CD, Caskey M, Robbiani DF, Rice CM, Nussenzweig MC, Hatziioannou T, Bieniasz PD. Escape from neutralizing antibodies by SARS-CoV-2 spike protein variants. eLife. 2020;9:e61312. Published 2020 Oct 28. https://doi.org/10.7554/elife.61312, PMID 33112236.

  • Whitfield ZJ, Prasad AN, Ronk AJ, Kuzmin IV, Ilinykh PA, Andino R, Bukreyev A. Species-specific evolution of Ebola virus during replication in human and bat cells. Cell Rep. 2020;32(7): https://doi.org/10.1016/j.celrep.2020.108028.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Wong MC, Javornik Cregeen SJ, Ajami NJ, Petrosino JF. Evidence of recombination in coronaviruses implicating pangolin origins of nCoV-2019. bioRxiv. 2020. https://doi.org/10.1101/2020.02.07.939207, PMID 32511310.

  • Wrapp D, Wang N, Corbett KS, Goldsmith JA, Hsieh CL, Abiona O, Graham BS, McLellan JS. Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation. Science. 2020;367(6483):1260–3. https://doi.org/10.1126/science.abb2507, PMID 32075877.

  • Wu A, Peng Y, Huang B, Ding X, Wang X, Niu P, Meng J, Zhu Z, Zhang Z, Wang J, Sheng J, Quan L, Xia Z, Tan W, Cheng G, Jiang T. Genome composition and divergence of the novel coronavirus (2019-nCoV) originating in China. Cell Host Microbe. 2020a;27(3):325–8. https://doi.org/10.1016/j.chom.2020.02.001, PMID 32035028.

  • Wu F, Zhao S, Yu B, Chen YM, Wang W, Song ZG, Hu Y, Tao ZW, Tian JH, Pei YY, Yuan ML, Zhang YL, Dai FH, Liu Y, Wang QM, Zheng JJ, Xu L, Holmes EC, Zhang YZ. A new coronavirus associated with human respiratory disease in China. Nature. 2020b;579(7798):265–9. https://doi.org/10.1038/s41586-020-2008-3, PMID 32015508.

  • Zhang L, Jackson CB, Mou H, Ojha A, Rangarajan ES, Izard T, Farzan M, Choe H. The D614G mutation in the SARS-CoV-2 spike protein reduces S1 shedding and increases infectivity. bioRxiv. 2020. https://doi.org/10.1101/2020.06.12.148726.

  • Zhao Z, Li H, Wu X, Zhong Y, Zhang K, Zhang YP, Boerwinkle E, Fu YX. Moderate mutation rate in the SARS coronavirus genome and its implications. BMC Evol Biol. 2004 Jun 28;4:21. https://doi.org/10.1186/1471-2148-4-21, PMID 15222897, PMCID PMC446188.

  • Zhou P, Yang XL, Wang XG, Hu B, Zhang L, Zhang W, Si HR, Zhu Y, Li B, Huang CL, Chen HD, Chen J, Luo Y, Guo H, Jiang RD, Liu MQ, Chen Y, Shen XR, Wang X, Zheng XS, Zhao K, Chen QJ, Deng F, Liu LL, Yan B, Zhan FX, Wang YY, Xiao GF, Shi ZL. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020;579(7798):270–3. https://doi.org/10.1038/s41586-020-2012-7, PMID 32015507.

  • Zhu N, Zhang D, Wang W, Li X, Yang B, Song J, Zhao X, Huang B, Shi W, Lu R, Niu P, Zhan F, Ma X, Wang D, Xu W, Wu G, Gao GF, Tan W, China Novel Coronavirus Investigating and Research Team. A Novel Coronavirus from Patients with Pneumonia in China, 2019. N Engl J Med. 2020;382(8):727–33. https://doi.org/10.1056/nejmoa2001017, PMID 31978945.

Download references

Acknowledgements

The authors greatly acknowledge Prof. C. Sheela Reddy, Principal, Sri Venkateswara College, University of Delhi, for her constant support.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Mansi Verma .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2021 The Author(s), under exclusive license to Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Phartyal, R., Verma, M. (2021). SARS-CoV-2 Mutations: An Insight. In: Ahmad, S.I. (eds) Human Viruses: Diseases, Treatments and Vaccines . Springer, Cham. https://doi.org/10.1007/978-3-030-71165-8_25

Download citation

Publish with us

Policies and ethics